Progress in the studies on small molecule IGF-1R inhibitors / 药学学报
Acta Pharmaceutica Sinica
;
(12): 979-984, 2008.
Artigo
em Chinês
| WPRIM
| ID: wpr-232656
ABSTRACT
The importance of insulin-like growth factor 1 receptor (IGF-1R) signaling in malignant behaviour of tumour cells is well established. Inhibiting the activity of IGF-1R may result in striking apoptosis in malignant cells growing. IGF-1R antibodies which are currently in phase I and II clinical trials and several IGF-IR TKIs have preclinically been characterized. This review describes recent developments of small molecule tyrosine kinase inhibitors.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Patologia
/
Farmacologia
/
Piperazinas
/
Piridonas
/
Pirimidinas
/
Pirróis
/
Benzimidazóis
/
Transdução de Sinais
/
Catequina
/
Química
Limite:
Animais
/
Humanos
Idioma:
Chinês
Revista:
Acta Pharmaceutica Sinica
Ano de publicação:
2008
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS